Skip to main content

Published locations for Pembrolizumab plus axitinib continues to outshine sunitinib for advanced RCC

Primary tabs

  • View
  • Get Stamp Tags
  • Published Locations

Breadcrumb

  1. Home
  3. Pembrolizumab plus axitinib continues to outshine sunitinib for advanced RCC

User login

  • Reset your password
  • /content/pembrolizumab-plus-axitinib-continues-outshine-sunitinib-advanced-rcc
  • /oncologypractice/article/231322/renal-cell-carcinoma/pembrolizumab-plus-axitinib-continues-outshine
  • /jcomjournal/article/231322/renal-cell-carcinoma/pembrolizumab-plus-axitinib-continues-outshine
  • /hematology-oncology/article/231322/renal-cell-carcinoma/pembrolizumab-plus-axitinib-continues